激活的淋巴细胞基免疫疗法加对照疗法在一个老年患者的第三阶段肺癌:一个案例报告
Anastasia Ganina1, Madina Karimova1, Dana Idrissova2
1JSC National Scientific Medical Center, 42 Abilay Khan Ave., Astana 010009, Kazakhstan.
Geriatrics (Basel, Switzerland)
|February 20, 2026
概括
这项研究表明,将免疫疗法与自身激活淋巴细胞和断层治疗结合起来,可以有效地治疗老年患者的晚期肺癌. 这种方法导致显著的瘤减少和改善患者的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射疗法 辐射疗法
背景情况:
- 肺癌,尤其是老年患者,死亡率很高.
- 免疫疗法,特别是使用自身激活免疫细胞,对肺癌治疗具有前景.
- 晚期肺癌的老年患者可能会从免疫疗法中受益,作为最后的手段.
研究的目的:
- 在接受组合治疗的老年患者中呈现晚期肺癌的临床病例.
- 为了评估免疫疗法的有效性,自主激活淋巴细胞与断层疗法相结合.
主要方法:
- 一名63岁的患者患有晚期肺癌和左主支气管透被治疗.
- 治疗包括使用自身激活淋巴细胞的免疫疗法和断层治疗.
- 通过瘤大小,循环瘤细胞和整体状况监测患者的反应.
主要成果:
- 结合治疗导致显著的瘤大小减少.
- 观察到循环瘤细胞的减少.
- 患者在治疗后一年以上仍然活着,身体状况良好.
结论:
- 结合免疫疗法和断层疗法是选择的高级肺癌老年患者的可行治疗选择.
- 这种方法提供了一种可靠的策略,用于改善这一患者群体的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K